16/01/2023
16/01/2023
SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins
19/12/2022
19/12/2022
EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe
19/12/2022
19/12/2022
The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry
25/04/2022
25/04/2022

Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

Do you like it?
Read more
08/09/2021
08/09/2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

Do you like it?
Read more
20/07/2021
20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

Do you like it?
Read more
12/02/2021
12/02/2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases.
Do you like it?
Read more